GLAUKOS Corp
Company Stats
- Market Cap
- $9.7B
- as of Sep 30, 2026
- Shares Outstanding
- 59.0M
- Free Float
- 96.6%
Income Statement
- Revenue
- $507.4M
- Operating Income
- -$199.6M
- Net Income
- -$187.7M
- EBITDA
- -$161.5M
- Revenue Growth, 3Y
- 21.5%
- FCF Margin, 3Y Avg
- -15.6%
- FCF Margin, Worst Year
- -24.8%
Cash Flow
- Free Cash Flow
- -$22.5M
- FCF Yield
- -0.2%
- Owner FCF Yield
- -0.9%
Balance Sheet
- Cash & Equivalents
- $90.8M
Returns & Capital
- SBC, 3Y Avg
- $52.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $507.4M | -$22.5M | -4.4% |
| FY2024 | $383.5M | -$67.6M | -17.6% |
| FY2023 | $314.7M | -$78.0M | -24.8% |
| FY2022 | $282.9M | -$63.3M | -22.4% |
| FY2021 | $294.0M | -$23.1M | -7.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back